Today is a great entry!
"It is estimated that up to 20% of the population have elevated Lp(a) levels that put them at higher risk for cardiovascular disease but because there has been no therapeutic option for lowering elevated Lp(a) levels . . ."
This, by far, could be the most successful drug they are developing. Potential target demographic of over 63 million Americans...I Believe this is the drug that ILIU partnered with.,..Does this mean that 63 million Americans need an ILIU genetic test to see if they have elevated Lp levels?
Abram Goldfinger, executive director of the Office of Industrial Liaison at NYU, stated, “Interleukin Genetics is a leader in the development of genetics-based tests to identify Interleukin-1 gene variations associated with inflammatory diseases, and we believe they are well positioned to commercialize this novel technology for the benefit of the millions of patients who suffer from this debilitating disease.”
Ski...What if our new CEO has an in with the "folks" at ObamaCare and has sold them the incredible opportunity to get in on the ground floor with their Perio test...and what if our new CEO said that the government can save $2500 per US citizen based on preventive care(Kind of what our wonderful president said about his healthcare plan) ...and what if the government forces all of us to be tested..."free" for us...but ILIU gets say $79 per test times say 100,000,000 people... Hey you never know!
Seems our "friend" Fartstein wrote about them all...